hsCRP
Conditions
Keywords
hsCRP
Brief summary
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Subjects with at least one clinic visit record within the last 12 months from the date of data entry. * Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry.
Exclusion criteria
* Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement * Active inflammatory diseases documented during the period of CRP measurement * Subjects taking immunosuppressants * Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate hs-CRP levels according to risk categories by the NCEP ATP III. | Within the last 12 months from the date of data entry. |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate a relationship between hs-CRP and each CHD CVD risk factor including LDL-C. | Within the last 12 months from the date of data entry. |
Countries
South Korea